Current filters:  
USA
Cannabis
United States
Wilson Elser Moskowitz Edelman & Dicker LLP
Ian Stewart (Partner-Los Angeles) authored the article "Regulatory Compliance More Accessible for Cannabis, Hemp Insurance Market," published...
Frantz Ward
Frantz Ward's Labor & Employment Group has previously written about the Ohio Bureau of Workers' Compensation's treatment of marijuana in its Drug-Free Safety Program (DFSP) following the legalization...
Davis+Gilbert LLP
You may have heard this before: As cannabis remains a Schedule I drug under the federal Controlled Substances Act ("CSA")...
Davis+Gilbert LLP
Yet, in the first year of legality, New York cannabis is struggling to generate the expected tax revenues for the state government, with a meager $70 million in legal sales as of August.
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana. This week, we see Texas' attorney general opposing local decriminalization laws.
Hyman, Phelps, & McNamara
With apologies to David Letterman, who introduced the first Top Ten List on Late Night with David Letterman on September 18, 1985...
Duane Morris LLP
A webinar replay of Mainstreaming Cannabis: Bankruptcy, Receiverships and Reorganization is now available for viewing.
Wilson Elser Moskowitz Edelman & Dicker LLP
Regulatory compliance is the single most important risk management tool for any cannabis or hemp company and its insurer.
Duane Morris LLP
Citing the facts that Pennsylvania (i) is bordered almost entirely by states that have legalized cannabis for adult use; (ii) loses millions to the black...
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
Wilentz, Goldman & Spitzer
For the December issue of the New Jersey Law Journal cannabis law column, Wilentz attorneys, Michael F. Schaff and Jennie M. Miller asked Christopher Riggs, chief counsel of the NJ-CRC, to respond to some questions that would...
Duane Morris LLP
As part of state regulations and general good manufacturing practices, many cannabis manufacturers test their products for contaminants such as mycotoxins, heavy metals and pesticides.
Sheppard Mullin Richter & Hampton
Join Sheppard Mullin's Cannabis Industry Team leaders as they recap 2023's major legislative and legal developments in the cannabis industry.
Seyfarth Shaw LLP
Republic Technologies (NA) LLC ("Republic") filed an application to register the proposed mark 4:20 with the United States Patent and Trademark Office ("USPTO"). Republic amended its goods twice during
Duane Morris LLP
On Wednesday, January 18, 2024, the NJ Cannabis Regulatory Commission (the "CRC") approved regulations to allow cannabis consumption lounges where consumers will be able to buy...
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana. This week, we note that HHS released...
Arnold & Porter
Howard Sklamberg, Life Sciences & Healthcare Regulatory partner, was quoted in Medscape and MarketWatch regarding the U.S. Department of Health and Human Services' (HHS)...
Hyman, Phelps, & McNamara
In August 2023 the Food and Drug Administration ("FDA") and Health and Human Services ("HHS") recommended that the Drug Enforcement Administration...
McGuireWoods LLP
On Jan. 12, 2024, the U.S. Department of Health and Human Services (HHS) officially released unredacted documents detailing the U.S. Food and Drug Administration's (FDA) reasons for recommending...
Carter Ledyard & Milburn
January 9, 2024 - As many industry participants know, 2023 was a challenging year for the Cannabis Industry (especially for the "adult use" market).
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Related Topics
Popular Contributors
Upcoming Events
MAR06
Mondaq Social Media